🧊 POLAR trial out in JAMA Oncology 🧊 Hand cooling & compression reduce taxane-induced neuropathy (CIPN) in BC pts (vs controlateral control arm) 📉Cooling: 29% vs. 50% CIPN (p=0.002) 📉Compression: 24% vs. 38% CIPN (p=0.008) #bcsm OncoAlert shorturl.at/LOXXQ

In-press link for our Phase I/II dose escalation trial of 3-fraction SRS for large brain metastasis resection cavities! redjournal.org/article/S0360-… I continue to be grateful for the mentorship of Dr. Scott Soltys, who is the definition of a true teacher and sponsor for trainees.

New research: Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for #oesophagealcancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial thelancet.com/journals/lanon…

SAKK A special thank you to Jeff Ryckman Jeff Ryckman, for actually proposing this!

HDR vs LDR Boost in Prostate Cancer: Is One Better? OncoAlert New RCT sheds light on long-term efficacy for unfavorable-risk prostate cancer 🎯 Objective Compare HDR vs LDR brachytherapy boost + EBRT in terms of biochemical control 🏥 Methods •190 👥 randomized: HDR (15 Gy

What is the optimal integration of SRS and CNS-active TKIs for brain metastases from EGFR & ALK+ NSCLC? New JAMA Oncology clinical evidence summary for this controversial topic The Pike Lab jamanetwork.com/journals/jamao…

Meningioma Grading Will Never Be the Same: 🔑 Takeaways from cIMPACT-NOW Update 8 OncoAlert For oncologists & radiation oncologists: here’s what you need to know about the molecular era of meningiomas🧵(1/14)

A question commonly asked- what is the role of embolization?…Stereotactic Radiosurgery With Versus Without Neoadjuvant... : Neurosurgery journals.lww.com/neurosurgery/a…

🔔Just published the first randomized trial comparing single-session vs. hypofractionated SRS for vestibular schwannoma 🔺 excellent post-radiosurgery tumor control rate 🔺 Mild side effects 👉 pubmed.ncbi.nlm.nih.gov/40222395/ IJROBP - The Red Journal #Radiosurgery #SRS #NeuroOncology #Schwannoma #radonc

1st part of #Radiotherapy Series that deep dives into #PORT for #Headneckcancer Thanks to ESTRO and Team led by Profs_Mererid & Vincent with superb colleagues Sue Yom Pierluigi Bonomo Part 2 on delineation otw! Must read for residents! thegreenjournal.com/article/S0167-…

💭Whether or not you believe in adverse radiation effect (ARE) after pre-op SRS, why deliver high doses to brain lesions when you can get away with less? This group found no difference in 2-year ✅cavity local recurrence ✅ARE ✅nodular leptomeningeal disease ✅OS between

#ASCO25: In pts with 5–20 brain mets, Phase 3 trial shows SRS/SRT leads to significantly better QoL vs HA-WBRT (↓ symptoms & interference, p<0.001), with no OS difference (8.3 vs 8.5 mo). SRS/SRT should be new SoC in this setting. #radonc 🔗 meetings.asco.org/abstracts-pres…

Pituitary metastasis are not common, but SRS is a terrific therapy for control. In this large series LC was 93% at 1 year. Don’t shy away, these can be controlled with low morbidity, don’t overlook this area on MRI. Intl Radiosurgery Research Foundation OhioStateRadOnc pubmed.ncbi.nlm.nih.gov/40442537/

#ASCO25 First RCT on steroid duration in mild ICI-pneumonitis 3-w vs 6-w corticosteroid therapy 👥 n:105 (G 1–2 pneumonitis) ✅ Tx success at 8 wks: 66.7% vs 85.2% → Non-inferiority not met❗️ 🔁 Relapse rate: 41% vs 24% ❗️Shorter 3-week regimen cannot replace standard

Grateful to see our latest study on foramen magnum meningiomas published in Neurosurgery. We reviewed our 35 years of experience at the first Gamma Knife center in North America. Deep thanks to my mentors and the incredible team who made this possible. Costas Hadjipanayis

❗️ Important work for SCLC 1-10 brain mets -> SRS mOS 10.2 m Only 22% of patients needed salvage WBRT Median 2 brain mets ascopubs.org/doi/10.1200/JC…

Proud to have contributed to more outstanding outcomes of cardiac radioablation for refractory ventricular tachycardia....this is the OSU experience led by cardiac EP Riz Afzal, & RO Jeremy Brownstein et al. In patients w/ 6mo follow-up, 89% ⬇️in ATP and 98% ⬇️in shocks. ⚡️⚡️⚡️

🆕article in press: Re-examining post-operative chemoradiotherapy in head and neck cancer: An updated long-term combined analysis of RTOG 9501/EORTC 22931 Sue Yom Allen S. Ho MD doi.org/10.1016/j.anno…

1/ Just published in IJROBP - The Red Journal: “Histological Classifier of Radiosensitivity to Spine SBRT.” doi.org/10.1016/j.ijro…

Nasser Altorki's team publishes new data investigating the role of preop SBRT for NSCLC. This time, reporting their institutional data comparing preop SBRT-IO vs Chemo-IO. The results demonstrate a significant association with improved RFS at 2 years with SBRT delivered BEFORE